Saturday, November 17, 2007

Merck agrees to US$4.85B settlement over Vioxx

From CTV News:
Merck & Co. has offered to pay US$4.85 billion to end litigation with thousands of U.S. plaintiffs over its painkiller Vioxx.

The agreement applies only to U.S. legal residents and those who allege that a heart attack or stroke they experienced while taking Vioxx occurred in the United States.

In Canada, negotiations continue in a number of class-action cases against the makers of Vioxx.

Mike Peerless, of Siskinds LLP, a law firm that represents hundreds of Canadian plaintiffs in Vioxx class actions, tells CTV that the settlement in the U.S. is a good sign and suggests that the company will want to quickly settle its Vioxx cases in Canada. ...more

No comments: